Ventura Clinical Trials

What Ventura Clinical Trials does

Ventura Clinical Trials (VCT) is a physician-owned, independent clinical research site founded by Dr. Sabine Hazan and Dr. Alon Steinberg, conducting Phase I through IV drug and device trials primarily in gastroenterology, hepatology, and cardiology, with additional programs in dermatology, rheumatology, nephrology, endocrinology, oncology, infectious disease, vaccines, and mental health. The company operates from headquarters in Ventura, California with additional offices in Westlake and Malibu, and is affiliated with two community hospitals (Community Memorial and Dignity Health facilities) plus a research collaboration with Brigham and Women's Hospital. It is positioned as the leading research group for the microbiome and gut bacteria, with active fecal microbiota transplantation (FMT) and microbiome-disease studies.

VCT's business model is enterprise B2B: it sells clinical-trial execution services to pharmaceutical and biotech sponsors, generating revenue through study design consultation, patient recruitment, regulatory compliance, data management, and quality assurance across full Phase I–IV studies. Patient recruitment is powered by a proprietary patient database combined with the Clinicaltrialsrecruit affiliation (social media, SEO, and music-label networks). Participants are paid for time and travel — disclosed compensation ranges from $900 for influenza studies to $1,460 for ulcerative colitis studies. The company reports no external funding, no parent company, and no private equity ownership; it is independently owned and co-led by its two physician founders.

Operationally, VCT differentiates on a 48-hour IRB approval turnaround, multi-specialty center access (endoscopy, cardiac, pathology, radiology), and a clean compliance record — no FDA Form 483 findings or major EMA findings after 23+ years and multiple audits. The competitive narrative rests on founder credentials, regulatory track record, and breadth of sponsor relationships (AstraZeneca, Amgen, Novartis, Merck, Roche, GSK, Boehringer Ingelheim, Daiichi Sankyo, Astellas, Janssen, Takeda, Parexel, and others), rather than on proprietary technology or scale.

Name

Ventura Clinical Trials

Legal name

Ventura Clinical Trials

Website

https://venturaclinicaltrials.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

Ventura Clinical Trials is a physician-owned, independent clinical research site in Ventura, California conducting Phase I–IV trials in gastroenterology, cardiology, microbiome, and other therapeutic areas for pharmaceutical and biotech sponsors.

Ownership category

akta.pro rank

Product category

Clinical Research Site Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGAAAA

Clinical CROs (Phase I–IV)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAKAEAL

Liver & GI Clinical Research (Trials Centers)

Healthcare & Life Sciences/Specialist Medical Practice/Gastroenterology & Hepatology

Keywords

• Clinical trial services
• Gastroenterology research
• Cardiology clinical trials
• Phase I-IV studies
• Microbiome research

Headquarters

HQ city

Ventura

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Clinical Trial Services: Revenue generated by conducting Phase I to IV clinical trials on behalf of pharmaceutical and biotech sponsors. Services include study design consultation, patient recruitment, regulatory compliance, data management, and quality assurance.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Ventura Clinical Trials is a physician-owned clinical research site that conducts Phase I through IV drug and device studies on behalf of pharmaceutical and biotech sponsors, with core specialization in gastroenterology, hepatology, cardiology, microbiome research, and fecal microbiota transplantation. The company recruits patients from its proprietary Ventura database and the affiliated Clinicaltrialsrecruit digital network, and delivers full-service trial execution including study start-up, patient recruitment, regulatory submissions, on-site procedures, and quality assurance at its Ventura, Westlake, and Malibu facilities.

Product overview

Ventura Clinical Trials (VCT) is a physician-owned clinical research organization founded by leading experts in Gastroenterology and Cardiology with over 23 years of experience. The company operates as a single unified clinical trials research service conducting Phase I to IV studies across multiple therapeutic areas. Their core offerings include clinical trials for gastrointestinal conditions (gastroparesis, ulcerative colitis, Crohn's disease, Clostridium difficile, fatty liver), metabolic disorders (diabetes, high cholesterol), cardiovascular diseases, autoimmune conditions (psoriasis, rheumatoid arthritis, renal failure), infectious diseases, vaccine studies, and mental health (postpartum depression). VCT is notably recognized as a leading research group for the Microbiome and gut Bacteria, offering fecal microbiota transplantation (FMT) research services. The company has facilities in Ventura, Westlake, and Malibu with access to private endoscopy centers, cardiac centers, pathology centers, and radiology services.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• No 483 or major findings from FDA and EMA audits over 23 years of operation
• +2 more outcomes

Named customers19 records

Segments9 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

13 partnerships are on record, tiered core, major and standard.

• ClinicaltrialsrecruitcoreGTM or Marketing PartnerAffiliated partner using social media platform, SEO platform to find patients, and a music label that provides access to millions of patients. This partnership enables cutting-edge marketing for patient recruitment across broad audiences.
• Malibu Specialty CentercoreStrategic or Co-development PartnerDr. Sabine Hazan is Founder/CEO of both Ventura Clinical Trials and Malibu Specialty Center. Provides specialty medical services and clinical trial capabilities in Malibu area.
• Community Memorial HospitalcoreStrategic or Co-development PartnerAffiliated community hospital providing patient access and clinical trial infrastructure. Dr. Alon Steinberg serves as Active Division Chief and Dr. Sabine Hazan is Past Chief of Medicine at this facility.
• St. John's HospitalmajorStrategic or Co-development PartnerAffiliated Dignity Health hospital providing additional patient access and clinical trial support for the Ventura region.
• Pleasant Valley HospitalmajorStrategic or Co-development PartnerAffiliated Dignity Health hospital providing additional clinical trial infrastructure and patient recruitment in the Ventura area.
• Cardiology AssociatesmajorStrategic or Co-development PartnerCardiology specialty practice partnership supporting cardiovascular clinical trials and patient referrals for cardiac-related studies.
• Ventura Surgical CentermajorImplementation/ SI/ Consulting PartnerSurgical center partnership providing operating facilities for clinical trial procedures and patient care.
• Gossman Imaging (Grossman Imaging Center)standardTechnology or IntegrationMedical imaging partner providing diagnostic imaging services for clinical trial assessments.
• Rolling Oaks RadiologystandardTechnology or IntegrationRadiology services partnership providing imaging diagnostics for clinical trial endpoints.
• Dianon PathologystandardTechnology or IntegrationPathology laboratory services for clinical trial specimen analysis and diagnostics.
• Quest DiagnosticsstandardTechnology or IntegrationMajor laboratory services provider for clinical trial testing and diagnostics.
• Pain Center (Cedars-Sinai)standardStrategic or Co-development PartnerPain management specialty center partnership supporting pain-related clinical trials.
• Brigham and Women's HospitalmajorStrategic or Co-development PartnerPrestigious Harvard-affiliated research hospital partnership providing research collaboration opportunities and academic credibility.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Medpace: Mid-sized CRO with strong physician-led, therapeutically-focused trial execution model; competes with VCT for sponsor studies across multiple therapeutic areas including gastroenterology and cardiovascular indications.
• Clinipace Worldwide: Mid-sized CRO offering full-service clinical research across multiple therapeutic areas including GI; comparable to VCT in scale, therapeutic focus, and physician-engaged trial execution model.
• Worldwide Clinical Trials: Mid-sized CRO focused on Phase I–IV clinical trials in CNS, cardiovascular, metabolic, and other specialty areas; directly comparable to VCT in therapeutic alignment and mid-scale site-based execution.
• Meridian Clinical Research: Site-management organization operating a network of physician-owned clinical trial sites across multiple therapeutic areas; directly comparable to VCT's physician-owned, multi-site, Phase I–IV site model.

Broad incumbents

• ICON plc: Major global CRO offering full Phase I–IV clinical trial services including site management; comparable in therapeutic breadth and sponsor base but operates at a fundamentally different scale than VCT.
• Syneos Health: Clinical and commercial solutions provider with global Phase I–IV CRO services; competes with VCT for sponsor relationships and shares therapeutic focus areas including gastroenterology.
• Parexel: Global CRO providing Phase I–IV clinical trial services; notable overlap as Parexel is also listed as one of VCT's enterprise customers, indicating both vendor-customer and competitive dynamics.
• IQVIA: Largest global CRO and clinical research services provider with extensive site-management and Phase I–IV capabilities; competes with VCT for sponsor contracts but at vastly greater scale and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/VenturaClinicalTrials
• LinkedInlinkedin.com/company/ventura-clinical-trials

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ventura Clinical Trials